TickerFactsScreenerDevelopers

Ensysce Biosciences, Inc. (ENSC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$1.24M2019: -$1.42M2020: -$1.25M2021: -$8.24M2022: -$17.89M2023: -$10.78M2024: -$7.50M2025: -$7.81M-$7.81M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.81M-4.0%
2024-$7.50M+30.4%
2023-$10.78M+39.7%
2022-$17.89M-117.0%
2021-$8.24M-560.8%
2020-$1.25M+12.5%
2019-$1.42M-15.1%
2018-$1.24M—